Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1999 Jul;54(7):629–637. doi: 10.1136/thx.54.7.629

Wegener's granulomatosis

C Langford 1, G Hoffman 1
PMCID: PMC1745525  PMID: 10377211

Full Text

The Full Text of this article is available as a PDF (271.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen N. B., Caldwell D. S., Rice J. R., McCallum R. M. Cyclosporin A therapy for Wegener's granulomatosis. Adv Exp Med Biol. 1993;336:473–476. doi: 10.1007/978-1-4757-9182-2_85. [DOI] [PubMed] [Google Scholar]
  2. Arimura Y., Minoshima S., Kamiya Y., Tanaka U., Nakabayashi K., Kitamoto K., Nagasawa T., Sasaki T., Suzuki K. Serum myeloperoxidase and serum cytokines in anti-myeloperoxidase antibody-associated glomerulonephritis. Clin Nephrol. 1993 Nov;40(5):256–264. [PubMed] [Google Scholar]
  3. Baltaro R. J., Hoffman G. S., Sechler J. M., Suffredini A. F., Shelhamer J. H., Fauci A. S., Fleisher T. A. Immunoglobulin G antineutrophil cytoplasmic antibodies are produced in the respiratory tract of patients with Wegener's granulomatosis. Am Rev Respir Dis. 1991 Feb;143(2):275–278. doi: 10.1164/ajrccm/143.2.275. [DOI] [PubMed] [Google Scholar]
  4. Barth J., Petermann W., Zemke F., Kreipe H., Gross W. L. Bronchoalveoläre Lavage bei Wegenerscher Granulomatose. Pneumologie. 1991 Jul;45(7):570–574. [PubMed] [Google Scholar]
  5. Berger S. P., Seelen M. A., Hiemstra P. S., Gerritsma J. S., Heemskerk E., van der Woude F. J., Daha M. R. Proteinase 3, the major autoantigen of Wegener's granulomatosis, enhances IL-8 production by endothelial cells in vitro. J Am Soc Nephrol. 1996 May;7(5):694–701. doi: 10.1681/ASN.V75694. [DOI] [PubMed] [Google Scholar]
  6. Charles L. A., Caldas M. L., Falk R. J., Terrell R. S., Jennette J. C. Antibodies against granule proteins activate neutrophils in vitro. J Leukoc Biol. 1991 Dec;50(6):539–546. doi: 10.1002/jlb.50.6.539. [DOI] [PubMed] [Google Scholar]
  7. Cotch M. F., Hoffman G. S., Yerg D. E., Kaufman G. I., Targonski P., Kaslow R. A. The epidemiology of Wegener's granulomatosis. Estimates of the five-year period prevalence, annual mortality, and geographic disease distribution from population-based data sources. Arthritis Rheum. 1996 Jan;39(1):87–92. doi: 10.1002/art.1780390112. [DOI] [PubMed] [Google Scholar]
  8. Csernok E., Ernst M., Schmitt W., Bainton D. F., Gross W. L. Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo. Clin Exp Immunol. 1994 Feb;95(2):244–250. doi: 10.1111/j.1365-2249.1994.tb06518.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Daum T. E., Specks U., Colby T. V., Edell E. S., Brutinel M. W., Prakash U. B., DeRemee R. A. Tracheobronchial involvement in Wegener's granulomatosis. Am J Respir Crit Care Med. 1995 Feb;151(2 Pt 1):522–526. doi: 10.1164/ajrccm.151.2.7842215. [DOI] [PubMed] [Google Scholar]
  10. Davenport A. "False positive" perinuclear and cytoplasmic anti-neutrophil cytoplasmic antibody results leading to misdiagnosis of Wegener's granulomatosis and/or microscopic polyarteritis. Clin Nephrol. 1992 Mar;37(3):124–130. [PubMed] [Google Scholar]
  11. Davies D. J., Moran J. E., Niall J. F., Ryan G. B. Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology? 1982 Aug 28-Sep 4Br Med J (Clin Res Ed) 285(6342):606–606. doi: 10.1136/bmj.285.6342.606. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. DeRemee R. A., McDonald T. J., Weiland L. H. Wegener's granulomatosis: observations on treatment with antimicrobial agents. Mayo Clin Proc. 1985 Jan;60(1):27–32. doi: 10.1016/s0025-6196(12)65279-3. [DOI] [PubMed] [Google Scholar]
  13. Deguchi Y., Shibata N., Kishimoto S. Enhanced expression of the tumour necrosis factor/cachectin gene in peripheral blood mononuclear cells from patients with systemic vasculitis. Clin Exp Immunol. 1990 Aug;81(2):311–314. doi: 10.1111/j.1365-2249.1990.tb03336.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Devaney K. O., Travis W. D., Hoffman G., Leavitt R., Lebovics R., Fauci A. S. Interpretation of head and neck biopsies in Wegener's granulomatosis. A pathologic study of 126 biopsies in 70 patients. Am J Surg Pathol. 1990 Jun;14(6):555–564. doi: 10.1097/00000478-199006000-00006. [DOI] [PubMed] [Google Scholar]
  15. Ewert B. H., Becker M. E., Jennette J. C., Falk R. J. Antimyeloperoxidase antibodies induce neutrophil adherence to cultured human endothelial cells. Ren Fail. 1995 Mar;17(2):125–133. doi: 10.3109/08860229509026249. [DOI] [PubMed] [Google Scholar]
  16. Falk R. J., Jennette J. C. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med. 1988 Jun 23;318(25):1651–1657. doi: 10.1056/NEJM198806233182504. [DOI] [PubMed] [Google Scholar]
  17. Falk R. J., Terrell R. S., Charles L. A., Jennette J. C. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci U S A. 1990 Jun;87(11):4115–4119. doi: 10.1073/pnas.87.11.4115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Fauci A. S., Haynes B. F., Katz P., Wolff S. M. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med. 1983 Jan;98(1):76–85. doi: 10.7326/0003-4819-98-1-76. [DOI] [PubMed] [Google Scholar]
  19. Grau G. E., Roux-Lombard P., Gysler C., Lambert C., Lambert P. H., Dayer J. M., Guillevin L. Serum cytokine changes in systemic vasculitis. Immunology. 1989 Oct;68(2):196–198. [PMC free article] [PubMed] [Google Scholar]
  20. Gross W. L. Antineutrophil cytoplasmic autoantibody testing in vasculitides. Rheum Dis Clin North Am. 1995 Nov;21(4):987–1011. [PubMed] [Google Scholar]
  21. Guillevin L., Cordier J. F., Lhote F., Cohen P., Jarrousse B., Royer I., Lesavre P., Jacquot C., Bindi P., Bielefeld P. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis. Arthritis Rheum. 1997 Dec;40(12):2187–2198. doi: 10.1002/art.1780401213. [DOI] [PubMed] [Google Scholar]
  22. Hadlow W. J., Race R. E., Kennedy R. C. Comparative pathogenicity of four strains of Aleutian disease virus for pastel and sapphire mink. Infect Immun. 1983 Sep;41(3):1016–1023. doi: 10.1128/iai.41.3.1016-1023.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Hagen E. C., Daha M. R., Hermans J., Andrassy K., Csernok E., Gaskin G., Lesavre P., Lüdemann J., Rasmussen N., Sinico R. A. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int. 1998 Mar;53(3):743–753. doi: 10.1046/j.1523-1755.1998.00807.x. [DOI] [PubMed] [Google Scholar]
  24. Hauschild S., Schmitt W. H., Csernok E., Flesch B. K., Rautmann A., Gross W. L. ANCA in systemic vasculitides, collagen vascular diseases, rheumatic disorders and inflammatory bowel diseases. Adv Exp Med Biol. 1993;336:245–251. doi: 10.1007/978-1-4757-9182-2_36. [DOI] [PubMed] [Google Scholar]
  25. Haynes B. F., Fishman M. L., Fauci A. S., Wolff S. M. The ocular manifestations of Wegener's granulomatosis. Fifteen years experience and review of the literature. Am J Med. 1977 Jul;63(1):131–141. doi: 10.1016/0002-9343(77)90125-5. [DOI] [PubMed] [Google Scholar]
  26. Henson J. B., Gorham J. R. Persistent viral infections, immunologically mediated glomerulonephritis and arteritis, dysgammopathies. Aleutian disease of mink. Am J Pathol. 1973 May;71(2):345–348. [PMC free article] [PubMed] [Google Scholar]
  27. Hoffman G. S., Kerr G. S., Leavitt R. Y., Hallahan C. W., Lebovics R. S., Travis W. D., Rottem M., Fauci A. S. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med. 1992 Mar 15;116(6):488–498. doi: 10.7326/0003-4819-116-6-488. [DOI] [PubMed] [Google Scholar]
  28. Hoffman G. S., Leavitt R. Y., Fleisher T. A., Minor J. R., Fauci A. S. Treatment of Wegener's granulomatosis with intermittent high-dose intravenous cyclophosphamide. Am J Med. 1990 Oct;89(4):403–410. doi: 10.1016/0002-9343(90)90367-m. [DOI] [PubMed] [Google Scholar]
  29. Hoffman G. S., Leavitt R. Y., Kerr G. S., Fauci A. S. The treatment of Wegener's granulomatosis with glucocorticoids and methotrexate. Arthritis Rheum. 1992 Nov;35(11):1322–1329. doi: 10.1002/art.1780351113. [DOI] [PubMed] [Google Scholar]
  30. Hoffman G. S., Sechler J. M., Gallin J. I., Shelhamer J. H., Suffredini A., Ognibene F. P., Baltaro R. J., Fleisher T. A., Leavitt R. Y., Travis W. D. Bronchoalveolar lavage analysis in Wegener's granulomatosis. A method to study disease pathogenesis. Am Rev Respir Dis. 1991 Feb;143(2):401–407. doi: 10.1164/ajrccm/143.2.401. [DOI] [PubMed] [Google Scholar]
  31. Hoffman G. S., Specks U. Antineutrophil cytoplasmic antibodies. Arthritis Rheum. 1998 Sep;41(9):1521–1537. doi: 10.1002/1529-0131(199809)41:9<1521::AID-ART2>3.0.CO;2-A. [DOI] [PubMed] [Google Scholar]
  32. Hollander D., Manning R. T. The use of alkylating agents in the treatment of Wegener's granulomatosis. Ann Intern Med. 1967 Aug;67(2):393–398. doi: 10.7326/0003-4819-67-2-393. [DOI] [PubMed] [Google Scholar]
  33. Israel H. L. Sulfamethoxazole-trimethoprim therapy for Wegener's granulomatosis. Arch Intern Med. 1988 Oct;148(10):2293–2295. [PubMed] [Google Scholar]
  34. Kerr G. S., Fleisher T. A., Hallahan C. W., Leavitt R. Y., Fauci A. S., Hoffman G. S. Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis. Arthritis Rheum. 1993 Mar;36(3):365–371. doi: 10.1002/art.1780360312. [DOI] [PubMed] [Google Scholar]
  35. King W. J., Adu D., Daha M. R., Brooks C. J., Radford D. J., Pall A. A., Savage C. O. Endothelial cells and renal epithelial cells do not express the Wegener's autoantigen, proteinase 3. Clin Exp Immunol. 1995 Oct;102(1):98–105. doi: 10.1111/j.1365-2249.1995.tb06642.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Langford C. A., Sneller M. C., Hallahan C. W., Hoffman G. S., Kammerer W. A., Talar-Williams C., Fauci A. S., Lebovics R. S. Clinical features and therapeutic management of subglottic stenosis in patients with Wegener's granulomatosis. Arthritis Rheum. 1996 Oct;39(10):1754–1760. doi: 10.1002/art.1780391020. [DOI] [PubMed] [Google Scholar]
  37. Langford C. A., Sneller M. C., Hoffman G. S. Methotrexate use in systemic vasculitis. Rheum Dis Clin North Am. 1997 Nov;23(4):841–853. doi: 10.1016/s0889-857x(05)70363-x. [DOI] [PubMed] [Google Scholar]
  38. Langford C. A. The diagnostic utility of c-ANCA in Wegener's granulomatosis. Cleve Clin J Med. 1998 Mar;65(3):135–140. doi: 10.3949/ccjm.65.3.135. [DOI] [PubMed] [Google Scholar]
  39. Lockwood C. M. New treatment strategies for systemic vasculitis: the role of intravenous immune globulin therapy. Clin Exp Immunol. 1996 May;104 (Suppl 1):77–82. [PubMed] [Google Scholar]
  40. Lúdvíksson B. R., Sneller M. C., Chua K. S., Talar-Williams C., Langford C. A., Ehrhardt R. O., Fauci A. S., Strober W. Active Wegener's granulomatosis is associated with HLA-DR+ CD4+ T cells exhibiting an unbalanced Th1-type T cell cytokine pattern: reversal with IL-10. J Immunol. 1998 Apr 1;160(7):3602–3609. [PubMed] [Google Scholar]
  41. Mayet W. J., Meyer zum Büschenfelde K. H. Antibodies to proteinase 3 increase adhesion of neutrophils to human endothelial cells. Clin Exp Immunol. 1993 Dec;94(3):440–446. doi: 10.1111/j.1365-2249.1993.tb08215.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Mayet W. J., Schwarting A., Meyer zum Büschenfelde K. H. Cytotoxic effects of antibodies to proteinase 3 (C-ANCA) on human endothelial cells. Clin Exp Immunol. 1994 Sep;97(3):458–465. doi: 10.1111/j.1365-2249.1994.tb06110.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Mayet W. J., Schwarting A., Orth T., Sibelius U., Hattar K., Meyer zum Büschenfelde K. H. Signal transduction pathways of membrane expression of proteinase 3 (PR-3) in human endothelial cells. Eur J Clin Invest. 1997 Nov;27(11):893–899. doi: 10.1046/j.1365-2362.1997.2160771.x. [DOI] [PubMed] [Google Scholar]
  44. Minick C. R., Fabricant C. G., Fabricant J., Litrenta M. M. Atheroarteriosclerosis induced by infection with a herpesvirus. Am J Pathol. 1979 Sep;96(3):673–706. [PMC free article] [PubMed] [Google Scholar]
  45. Niles J. L., McCluskey R. T., Ahmad M. F., Arnaout M. A. Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase. Blood. 1989 Nov 1;74(6):1888–1893. [PubMed] [Google Scholar]
  46. Nishino H., Rubino F. A., DeRemee R. A., Swanson J. W., Parisi J. E. Neurological involvement in Wegener's granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic. Ann Neurol. 1993 Jan;33(1):4–9. doi: 10.1002/ana.410330103. [DOI] [PubMed] [Google Scholar]
  47. Noronha I. L., Krüger C., Andrassy K., Ritz E., Waldherr R. In situ production of TNF-alpha, IL-1 beta and IL-2R in ANCA-positive glomerulonephritis. Kidney Int. 1993 Mar;43(3):682–692. doi: 10.1038/ki.1993.98. [DOI] [PubMed] [Google Scholar]
  48. Nölle B., Specks U., Lüdemann J., Rohrbach M. S., DeRemee R. A., Gross W. L. Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener granulomatosis. Ann Intern Med. 1989 Jul 1;111(1):28–40. doi: 10.7326/0003-4819-111-1-28. [DOI] [PubMed] [Google Scholar]
  49. Pignone A., Scaletti C., Matucci-Cerinic M., Vázquez-Abad D., Meroni P. L., Del Papa N., Falcini F., Generini S., Rothfield N., Cagnoni M. Anti-endothelial cell antibodies in systemic sclerosis: significant association with vascular involvement and alveolo-capillary impairment. Clin Exp Rheumatol. 1998 Sep-Oct;16(5):527–532. [PubMed] [Google Scholar]
  50. Presti R. M., Pollock J. L., Dal Canto A. J., O'Guin A. K., Virgin H. W., 4th Interferon gamma regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels. J Exp Med. 1998 Aug 3;188(3):577–588. doi: 10.1084/jem.188.3.577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Radis C. D., Kahl L. E., Baker G. L., Wasko M. C., Cash J. M., Gallatin A., Stolzer B. L., Agarwal A. K., Medsger T. A., Jr, Kwoh C. K. Effects of cyclophosphamide on the development of malignancy and on long-term survival of patients with rheumatoid arthritis. A 20-year followup study. Arthritis Rheum. 1995 Aug;38(8):1120–1127. doi: 10.1002/art.1780380815. [DOI] [PubMed] [Google Scholar]
  52. Ralston D. R., Marsh C. B., Lowe M. P., Wewers M. D. Antineutrophil cytoplasmic antibodies induce monocyte IL-8 release. Role of surface proteinase-3, alpha1-antitrypsin, and Fcgamma receptors. J Clin Invest. 1997 Sep 15;100(6):1416–1424. doi: 10.1172/JCI119662. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Rao J. K., Weinberger M., Oddone E. Z., Allen N. B., Landsman P., Feussner J. R. The role of antineutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener granulomatosis. A literature review and meta-analysis. Ann Intern Med. 1995 Dec 15;123(12):925–932. doi: 10.7326/0003-4819-123-12-199512150-00005. [DOI] [PubMed] [Google Scholar]
  54. Reinhold-Keller E., Kekow J., Schnabel A., Schmitt W. H., Heller M., Beigel A., Duncker G., Gross W. L. Influence of disease manifestation and antineutrophil cytoplasmic antibody titer on the response to pulse cyclophosphamide therapy in patients with Wegener's granulomatosis. Arthritis Rheum. 1994 Jun;37(6):919–924. doi: 10.1002/art.1780370622. [DOI] [PubMed] [Google Scholar]
  55. Richter C., Schnabel A., Csernok E., Reinhold-Keller E., Gross W. L. Treatment of Wegener's granulomatosis with intravenous immunoglobulin. Adv Exp Med Biol. 1993;336:487–489. doi: 10.1007/978-1-4757-9182-2_88. [DOI] [PubMed] [Google Scholar]
  56. Savage C. O., Gaskin G., Pusey C. D., Pearson J. D. Anti-neutrophil cytoplasm antibodies can recognize vascular endothelial cell-bound anti-neutrophil cytoplasm antibody-associated autoantigens. Exp Nephrol. 1993 May-Jun;1(3):190–195. [PubMed] [Google Scholar]
  57. Sneller M. C., Hoffman G. S., Talar-Williams C., Kerr G. S., Hallahan C. W., Fauci A. S. An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone. Arthritis Rheum. 1995 May;38(5):608–613. doi: 10.1002/art.1780380505. [DOI] [PubMed] [Google Scholar]
  58. Stegeman C. A., Tervaert J. W., de Jong P. E., Kallenberg C. G. Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group. N Engl J Med. 1996 Jul 4;335(1):16–20. doi: 10.1056/NEJM199607043350103. [DOI] [PubMed] [Google Scholar]
  59. Talar-Williams C., Hijazi Y. M., Walther M. M., Linehan W. M., Hallahan C. W., Lubensky I., Kerr G. S., Hoffman G. S., Fauci A. S., Sneller M. C. Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis. Ann Intern Med. 1996 Mar 1;124(5):477–484. doi: 10.7326/0003-4819-124-5-199603010-00003. [DOI] [PubMed] [Google Scholar]
  60. Tervaert J. W., Huitema M. G., Hené R. J., Sluiter W. J., The T. H., van der Hem G. K., Kallenberg C. G. Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet. 1990 Sep 22;336(8717):709–711. doi: 10.1016/0140-6736(90)92205-v. [DOI] [PubMed] [Google Scholar]
  61. Tervaert J. W., van der Woude F. J., Fauci A. S., Ambrus J. L., Velosa J., Keane W. F., Meijer S., van der Giessen M., van der Hem G. K., The T. H. Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Intern Med. 1989 Nov;149(11):2461–2465. doi: 10.1001/archinte.149.11.2461. [DOI] [PubMed] [Google Scholar]
  62. Travis W. D., Hoffman G. S., Leavitt R. Y., Pass H. I., Fauci A. S. Surgical pathology of the lung in Wegener's granulomatosis. Review of 87 open lung biopsies from 67 patients. Am J Surg Pathol. 1991 Apr;15(4):315–333. doi: 10.1097/00000478-199104000-00001. [DOI] [PubMed] [Google Scholar]
  63. WALTON E. W. Giant-cell granuloma of the respiratory tract (Wegener's granulomatosis). Br Med J. 1958 Aug 2;2(5091):265–270. doi: 10.1136/bmj.2.5091.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Weck K. E., Dal Canto A. J., Gould J. D., O'Guin A. K., Roth K. A., Saffitz J. E., Speck S. H., Virgin H. W. Murine gamma-herpesvirus 68 causes severe large-vessel arteritis in mice lacking interferon-gamma responsiveness: a new model for virus-induced vascular disease. Nat Med. 1997 Dec;3(12):1346–1353. doi: 10.1038/nm1297-1346. [DOI] [PubMed] [Google Scholar]
  65. Weyand C. M., Hicok K. C., Hunder G. G., Goronzy J. J. Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis. Ann Intern Med. 1994 Oct 1;121(7):484–491. doi: 10.7326/0003-4819-121-7-199410010-00003. [DOI] [PubMed] [Google Scholar]
  66. de Bandt M., Ollivier V., Meyer O., Babin-Chevaye C., Khechaï F., de Prost D., Hakim J., Pasquier C. Induction of interleukin-1 and subsequent tissue factor expression by anti-proteinase 3 antibodies in human umbilical vein endothelial cells. Arthritis Rheum. 1997 Nov;40(11):2030–2038. doi: 10.1002/art.1780401116. [DOI] [PubMed] [Google Scholar]
  67. de Groot K., Reinhold-Keller E., Tatsis E., Paulsen J., Heller M., Nölle B., Gross W. L. Therapy for the maintenance of remission in sixty-five patients with generalized Wegener's granulomatosis. Methotrexate versus trimethoprim/sulfamethoxazole. Arthritis Rheum. 1996 Dec;39(12):2052–2061. doi: 10.1002/art.1780391215. [DOI] [PubMed] [Google Scholar]
  68. van der Woude F. J., Rasmussen N., Lobatto S., Wiik A., Permin H., van Es L. A., van der Giessen M., van der Hem G. K., The T. H. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet. 1985 Feb 23;1(8426):425–429. doi: 10.1016/s0140-6736(85)91147-x. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES